Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | IBRX |
---|---|---|
09:32 ET | 76492 | 5.2347 |
09:33 ET | 52663 | 5.3 |
09:35 ET | 42758 | 5.25 |
09:37 ET | 26267 | 5.3098 |
09:39 ET | 41722 | 5.36 |
09:42 ET | 28668 | 5.4012 |
09:44 ET | 46885 | 5.37 |
09:46 ET | 30985 | 5.335 |
09:48 ET | 16265 | 5.29 |
09:50 ET | 18358 | 5.29 |
09:51 ET | 43723 | 5.175 |
09:53 ET | 33133 | 5.205 |
09:55 ET | 13822 | 5.2 |
09:57 ET | 77884 | 5.175 |
10:00 ET | 27883 | 5.22 |
10:02 ET | 86407 | 5.2103 |
10:04 ET | 15780 | 5.21 |
10:06 ET | 11923 | 5.23 |
10:08 ET | 11174 | 5.2395 |
10:09 ET | 2298 | 5.22 |
10:11 ET | 12138 | 5.22 |
10:13 ET | 13789 | 5.195 |
10:15 ET | 13385 | 5.195 |
10:18 ET | 8722 | 5.195 |
10:20 ET | 12668 | 5.225 |
10:22 ET | 16194 | 5.23 |
10:24 ET | 6802 | 5.235 |
10:26 ET | 10398 | 5.275 |
10:27 ET | 25678 | 5.325 |
10:29 ET | 40012 | 5.2992 |
10:31 ET | 24366 | 5.29 |
10:33 ET | 12012 | 5.31 |
10:36 ET | 39469 | 5.27 |
10:38 ET | 11065 | 5.285 |
10:40 ET | 12120 | 5.2999 |
10:42 ET | 23405 | 5.285 |
10:44 ET | 6192 | 5.28 |
10:45 ET | 10118 | 5.295 |
10:47 ET | 5190 | 5.2926 |
10:49 ET | 29050 | 5.3091 |
10:51 ET | 20797 | 5.33 |
10:54 ET | 4103 | 5.325 |
10:56 ET | 1002 | 5.3206 |
10:58 ET | 29042 | 5.33 |
11:00 ET | 2550 | 5.305 |
11:02 ET | 26965 | 5.2806 |
11:03 ET | 3908 | 5.28 |
11:05 ET | 1856 | 5.295 |
11:07 ET | 549 | 5.29 |
11:09 ET | 3093 | 5.285 |
11:12 ET | 18906 | 5.2583 |
11:14 ET | 4858 | 5.255 |
11:16 ET | 5953 | 5.2599 |
11:18 ET | 36931 | 5.25 |
11:20 ET | 13269 | 5.275 |
11:21 ET | 10939 | 5.28 |
11:23 ET | 9085 | 5.255 |
11:25 ET | 7707 | 5.255 |
11:27 ET | 3865 | 5.255 |
11:30 ET | 2006 | 5.25 |
11:32 ET | 13583 | 5.245 |
11:34 ET | 22333 | 5.258 |
11:36 ET | 18286 | 5.245 |
11:38 ET | 9218 | 5.2211 |
11:39 ET | 7100 | 5.235 |
11:41 ET | 3365 | 5.2593 |
11:43 ET | 6693 | 5.245 |
11:45 ET | 1679 | 5.235 |
11:48 ET | 2460 | 5.2289 |
11:50 ET | 3468 | 5.225 |
11:52 ET | 7026 | 5.235 |
11:54 ET | 11872 | 5.265 |
11:56 ET | 1987 | 5.26 |
11:57 ET | 963 | 5.26 |
11:59 ET | 3199 | 5.26 |
12:01 ET | 2301 | 5.245 |
12:03 ET | 1792 | 5.22 |
12:06 ET | 11912 | 5.23 |
12:08 ET | 1648 | 5.205 |
12:10 ET | 4282 | 5.206 |
12:12 ET | 8035 | 5.206 |
12:14 ET | 11539 | 5.175 |
12:15 ET | 54260 | 5.1288 |
12:17 ET | 47078 | 5.125 |
12:19 ET | 10803 | 5.105 |
12:21 ET | 25343 | 5.08 |
12:24 ET | 13234 | 5.066 |
12:26 ET | 5816 | 5.06 |
12:28 ET | 21833 | 5.09 |
12:30 ET | 16957 | 5.068 |
12:32 ET | 5498 | 5.0788 |
12:33 ET | 5676 | 5.09 |
12:35 ET | 11900 | 5.09 |
12:37 ET | 2602 | 5.09 |
12:39 ET | 9662 | 5.11 |
12:42 ET | 15279 | 5.085 |
12:44 ET | 7925 | 5.105 |
12:46 ET | 9517 | 5.095 |
12:48 ET | 19829 | 5.065 |
12:50 ET | 5670 | 5.069 |
12:51 ET | 5889 | 5.065 |
12:53 ET | 62057 | 5.07 |
12:55 ET | 3014 | 5.0628 |
12:57 ET | 6132 | 5.0578 |
01:00 ET | 21813 | 5.07 |
01:02 ET | 3905 | 5.07 |
01:04 ET | 1643 | 5.07 |
01:06 ET | 9208 | 5.07 |
01:08 ET | 2031 | 5.0605 |
01:09 ET | 2568 | 5.0689 |
01:11 ET | 7113 | 5.06 |
01:13 ET | 5694 | 5.07 |
01:15 ET | 2944 | 5.065 |
01:18 ET | 6795 | 5.06 |
01:20 ET | 4772 | 5.065 |
01:22 ET | 3071 | 5.065 |
01:24 ET | 3616 | 5.065 |
01:26 ET | 4463 | 5.075 |
01:27 ET | 2154 | 5.08 |
01:29 ET | 1538 | 5.0786 |
01:31 ET | 20725 | 5.0994 |
01:33 ET | 25309 | 5.095 |
01:36 ET | 18653 | 5.115 |
01:38 ET | 2304 | 5.115 |
01:40 ET | 3876 | 5.085 |
01:42 ET | 1846 | 5.0829 |
01:44 ET | 3702 | 5.09 |
01:45 ET | 1284 | 5.066 |
01:47 ET | 59256 | 5.0708 |
01:49 ET | 28366 | 5.033 |
01:51 ET | 6224 | 5.02 |
01:54 ET | 3163 | 5.0206 |
01:56 ET | 7132 | 5.03 |
01:58 ET | 1860 | 5.034 |
02:00 ET | 40323 | 5.0276 |
02:02 ET | 3558 | 5.0346 |
02:03 ET | 17410 | 5.055 |
02:05 ET | 1495 | 5.0555 |
02:07 ET | 7593 | 5.075 |
02:09 ET | 2809 | 5.08 |
02:12 ET | 5621 | 5.075 |
02:14 ET | 20427 | 5.0822 |
02:16 ET | 3935 | 5.08 |
02:18 ET | 200 | 5.07 |
02:20 ET | 1536 | 5.07 |
02:21 ET | 3162 | 5.07 |
02:23 ET | 1650 | 5.06 |
02:25 ET | 4052 | 5.066 |
02:27 ET | 6400 | 5.0681 |
02:30 ET | 5248 | 5.075 |
02:32 ET | 7131 | 5.07 |
02:34 ET | 1600 | 5.07 |
02:36 ET | 1649 | 5.065 |
02:38 ET | 653 | 5.065297 |
02:39 ET | 1367 | 5.065 |
02:41 ET | 202 | 5.06 |
02:43 ET | 5270 | 5.065 |
02:45 ET | 13646 | 5.085 |
02:48 ET | 2000 | 5.09 |
02:50 ET | 4511 | 5.08 |
02:52 ET | 1874 | 5.089 |
02:54 ET | 1581 | 5.0837 |
02:56 ET | 1060 | 5.0749 |
02:57 ET | 5191 | 5.065 |
02:59 ET | 1537 | 5.0606 |
03:01 ET | 22089 | 5.075 |
03:03 ET | 1583 | 5.08 |
03:06 ET | 2805 | 5.065 |
03:08 ET | 1536 | 5.07 |
03:10 ET | 9528 | 5.09 |
03:12 ET | 10171 | 5.0829 |
03:14 ET | 889 | 5.085 |
03:15 ET | 5250 | 5.09 |
03:17 ET | 6897 | 5.0905 |
03:19 ET | 4742 | 5.0899 |
03:21 ET | 8296 | 5.09 |
03:24 ET | 11538 | 5.085 |
03:26 ET | 76493 | 5.0402 |
03:28 ET | 11164 | 5.04 |
03:30 ET | 6683 | 5.044 |
03:32 ET | 17636 | 5.05 |
03:33 ET | 8101 | 5.065 |
03:35 ET | 2790 | 5.08 |
03:37 ET | 12448 | 5.0788 |
03:39 ET | 2186 | 5.065 |
03:42 ET | 10270 | 5.08 |
03:44 ET | 9710 | 5.075 |
03:46 ET | 6355 | 5.06 |
03:48 ET | 9145 | 5.0589 |
03:50 ET | 11385 | 5.045 |
03:51 ET | 7315 | 5.06 |
03:53 ET | 13632 | 5.06 |
03:55 ET | 9765 | 5.05 |
03:57 ET | 24836 | 5.06 |
04:00 ET | 284944 | 5.04 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Immunitybio Inc | 3.6B | -5.8x | --- |
MoonLake Immunotherapeutics | 3.5B | -42.1x | --- |
Verona Pharma PLC | 3.2B | -20.9x | --- |
Immunovant Inc | 3.9B | -12.1x | --- |
Xenon Pharmaceuticals Inc | 3.1B | -14.8x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Immunitybio, Inc. is a vertically integrated, clinical-stage biotechnology company developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. Using its proprietary platforms that amplify both the innate and adaptive branches of the immune system, its advances therapies and vaccines to defeat urologic and other cancers, as well as infectious diseases. Its platforms and their associated product candidates are designed to attack cancer and infectious pathogens by activating both the innate immune system, including NK cells, dendritic cells, and macrophages, as well as the adaptive immune system comprising, B and T cells, in an orchestrated manner. Its platforms for the development of biologic product candidates include antibody-cytokine fusion proteins; DNA, RNA and recombinant protein vaccines, and cell therapies. Its lead biologic commercial product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.6B |
---|---|
Revenue (TTM) | $7.3M |
Shares Outstanding | 696.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.75 |
EPS | $-0.87 |
Book Value | $-0.87 |
P/E Ratio | -5.8x |
Price/Sales (TTM) | 484.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -4,912.32% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.